Acurx Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 31.10 K | $48.20 K | 0.00% | 0.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 26.41 K | $40.94 K | 6.41% | 0.62% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 16.21 K | $25.12 K | 0.00% | 0.38% |
| JANE STREET GROUP, LLC | 08/14/2026 | 15.73 K | $24.38 K | -71.22% | 0.37% |
| PROSPECT FINANCIAL SERVICES LLC | 08/06/2026 | 13.79 K | $21.37 K | 0.00% | 0.32% |
| MORGAN STANLEY | 08/13/2026 | 7.50 K | $11.63 K | 15.38% | 0.18% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 4.73 K | $7.33 K | 100.00% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 2.74 K | $4.25 K | 166.15% | 0.06% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 2.30 K | $3.57 K | 0.00% | 0.05% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 07/27/2026 | 1.65 K | $2.56 K | 0.00% | 0.04% |
| NBC SECURITIES, INC. | 07/21/2026 | 1.50 K | $2.33 K | 0.00% | 0.04% |
| BARCLAYS PLC | 08/14/2026 | 281 | $436 | -26.05% | 0.01% |
| CORNERSTONE PLANNING GROUP LLC | 07/29/2026 | 167 | $245 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 100 | $155 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 95 | $147 | -61.22% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 60 | $93 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 23 | $36 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 6 | $9 | 0.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 3 | $5 | -99.95% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/30/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WESTERN WEALTH MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MCGUIRE CAPITAL ADVISORS INC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acurx Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Acurx Pharmaceuticals Inc. The most heavily invested institutionals were:
VANGUARD CAPITAL MANAGEMENT LLC: 31,099
GEODE CAPITAL MANAGEMENT, LLC: 26,411
VANGUARD FIDUCIARY TRUST CO: 16,205
JANE STREET GROUP, LLC: 15,727
Prospect Financial Services LLC: 13,785
MORGAN STANLEY: 7,500
2.92% of Acurx Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 176.52 K shares in the last 24 months. This purchase volume represents approximately $345.98 K in transactions.